Nov 2, 2026 07:00AM
Sep 15, 2026 07:01AM
Sep 15, 2026 07:00AM
Aug 3, 2026 07:19AM
Aug 3, 2026 07:00AM
Jul 17, 2026 05:17AM
Jun 17, 2026 08:45AM Ocular Therapeutix plans wet AMD drug filing for late 2026
Jun 17, 2026 08:45AM
May 5, 2026 07:22AM
May 5, 2026 07:00AM
Apr 29, 2026 07:00AM
Apr 29, 2026 07:00AM
Apr 28, 2026 07:00AM
Apr 13, 2026 07:01AM Ocular Therapeutix reports additional week 52 data from wet AMD trial
Apr 13, 2026 07:00AM
Feb 17, 2026 07:02AM
Feb 17, 2026 07:00AM
Feb 5, 2026 07:43AM
Feb 5, 2026 07:00AM
Jan 21, 2026 07:00AM
Jan 21, 2026 07:00AM Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer
Dec 8, 2025 07:02AM
Dec 8, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 4, 2025 07:12AM
Nov 4, 2025 07:05AM
Nov 4, 2025 07:02AM Ocular Therapeutix completes enrollment in wet AMD drug trial
Nov 4, 2025 07:00AM
Oct 28, 2025 07:00AM
Sep 30, 2025 06:21AM
Sep 30, 2025 06:21AM
Aug 12, 2025 07:01AM
Aug 12, 2025 07:00AM
Aug 5, 2025 11:11AM Clear Street Reiterates Buy Rating on Ocular Therapeutix (OCUL)
Aug 5, 2025 11:07AM
Aug 5, 2025 07:13AM
Aug 5, 2025 07:00AM
Jul 29, 2025 07:00AM
May 5, 2025 07:04AM
May 5, 2025 07:00AM
Apr 28, 2025 07:00AM Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025
Mar 4, 2025 06:42AM
Mar 3, 2025 07:10AM
Mar 3, 2025 07:00AM
Feb 24, 2025 07:00AM
Jan 14, 2025 07:03AM
Jan 14, 2025 07:00AM
Dec 2, 2024 07:30AM Ocular Therapeutix™ Announces More Than 300 Subjects Randomized in SOL-1
Nov 15, 2024 06:51AM

1,239,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All